GENE ONLINE|News &
Opinion
Blog

Tyrosine Kinase
Novartis Announces Failure of Ruxolitinib Trial in Severe COVID-19
2020-12-18
Seattle Genetics Enters Breast Cancer Market with Tukysa
2020-04-21
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
LATEST
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
Healthcare Revolution: Leeuwenhoek Joins Hands with Key Companies and Experts at Healthcare+ Expo Taiwan 2024
2024-12-11
Protect Animal Health and Rejuvenate Bio Partner to Tackle Canine Heart Disease
2024-12-11
2024 Taiwan Healthcare+ Expo: Innovations in Five Key Industries
2024-12-11
EVENT
Scroll to Top